Insulet (PODD) Tops Q4 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Insulet Corporation (PODD) PT Lowered to $310 at BTIG
February 24, 2022 12:59 PM ESTBTIG analyst Marie Thibault lowered the price target on Insulet Corporation (NASDAQ: PODD) to $310.00 (from $320.00) while maintaining a Buy rating.
The analyst commented, "Insulet reported Q4 revenue of $307.7M (+25% y/y rep, +25.7% y/y cc), beating consensus estimates of $299.3M and our $303.2M forecast. U.S. Omnipod revenue was relatively in line with our expectations but OUS headwinds, including ongoing pressures from competitive AID systems and an estimated $5M... More
